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Long-term in-vivo electrochemistry (LIVE) enables real-time monitoring and measurement of brain
metabolites. In this study we have simultaneously obtained blood oxygenation level dependent (BOLD)
fMRI and amperometric tissue O2 data from rat cerebral cortex, during both increases and decreases in
inspired O2 content. BOLD and tissue O2 measurements demonstrated close correlation (r=0.7898) during
complete (0%) O2 removal, with marked negative responses occurring ca. 30 s after the onset of O2 removal.
Conversely, when the inspired O2 was increased (50, 70 and 100% O2 for 1 min) similar positive rapid
changes (ca. 15 s) in both the BOLD and tissue O2 signals were observed. These findings demonstrate, for the
first time, the practical feasibility of obtaining real-time metabolite information during fMRI acquisition, and
that tissue O2 concentration monitored using an O2 sensor can serve as an index of changes in the magnitude
of the BOLD response. As LIVE O2 sensors can be used in awake animals performing specific behavioural tasks
the technique provides a viable animal surrogate of human fMRI experimentation.
© 2010 Elsevier Inc. All rights reserved.
Introduction
Increases in neuronal activity are accompanied by changes in
cerebral blood flow, blood volume and oxygenation that are
collectively referred to as the hemodynamic response. Such changes
form the basis of imaging techniques such as blood oxygenation level
dependent (BOLD) functional magnetic resonance imaging (fMRI)
(Bandettini et al., 1992; Ogawa et al., 1992). BOLD fMRI is a key tool in
neuroscience because it provides a powerful non-invasive way of
mapping the regional activity of the brain during the performance of
sensory, motor or cognitive tasks. Image resolution to a few hundred
micron also means that detailed structural and functional imaging
data can be acquired in small laboratory animals (Houston et al., 2001;
Jones et al., 2005; Preece, et al., 2001). However, motion constraints
necessitate the use of anaesthetics in the majority of studies, thus
limiting the functional processes that can be engaged whilst the
animal is being scanned and potentially altering circuitry
engagement.
The MRI signal intensity is sensitive to the amount of O2 carried by
haemoglobin: a change in the amount of O2 carried by haemoglobin
changes the degree to which haemoglobin disturbs a magnetic field
(Westerink and Cremers, 2007). Thus, an increase in haemoglobin
oxygenation compared to baseline results in an increased BOLD signal,
and conversely greater deoxygenation leads to a negative BOLD
response. Tissue O2 is related to deoxyhaemoglobin through the
oxygen-haemoglobin dissociation curve and the local O2 concentra-
tion gradient. Using a dual microelectrode and Clark oxygen electrode,
Thompson et al. (2003) made simultaneous co-localised extracellular
measurements of tissue O2 and neural activity in cat cerebral cortex
and established a coupling between neural activity and oxidative
metabolism. Later work has suggested that tissue O2 concentration is
more closely associated with synaptic activity and local field
potentials than spiking events (Viswanathan and Freeman, 2007).
However, data from imaging techniques remains difficult to interpret
in terms of the underlying neuronal activity, largely because one of
the principle factors influencing blood oxygenation, the cerebral
metabolic rate of O2 consumption (CMRO2), is poorly understood. In
particular, how neurometabolic changes vary temporally, spatially
and in magnitude remains uncertain. Recent in-vivo studies using
microelectrodes to measure cerebral tissue O2 in real-time during
sensory stimulation have begun to address these issues (Ances et al.,
2001; Masamoto et al., 2003, 2008; Offenhauser et al., 2005). Results
from such experiments can be compared with both optical and fMRI
NeuroImage 52 (2010) 549–555
⁎ Corresponding author. Fax: +353 1 708 3815.
E-mail address: John.Lowry@nuim.ie (J.P. Lowry).
1 Present address: UCD School of Medicine and Medical Science, Belfield, Dublin 4,
Ireland.
2 Present address: Experimental Neuroimaging Group, Old Road Campus Research
Building, Roosevelt Drive, Oxford OX3 7DQ, UK.
1053-8119/$ – see front matter © 2010 Elsevier Inc. All rights reserved.
doi:10.1016/j.neuroimage.2010.04.187
Contents lists available at ScienceDirect
NeuroImage
j ourna l homepage: www.e lsev ie r.com/ locate /yn img
Author's personal copy
imaging data in order to understand the important relationship
between metabolic and haemodynamic changes associated with
increases in neuronal activity (Bartlett et al., 2008). While such
comparisons have yielded useful insights into these processes a
significant limitation is that data are being compared across different
experiments.
The aim of the current study, therefore, was to develop and
validate techniques for the simultaneous measurement of fMRI
responses and tissue O2 concentration. We show here that this can
be achieved in the rat by in situ long-term in-vivo electrochemistry
(LIVE). LIVE focuses on the detection of substances in extracellular
fluid (ECF) using electrochemistry with implanted amperometric
sensors and biosensors. By implanting a microelectrode in a specific
brain region, applying a suitable potential profile and recording the
resulting Faradaic current, changes in the concentration of a variety of
ECF species can be monitored. LIVE offers excellent spatial (∼10 μm)
and temporal (millisecond) resolutions, and a major advantage of
long-term stability (continuous monitoring in vivo over several
weeks) (Lowry and O'Neill, 2005; O'Neill, 1994; O'Neill et al., 1998;
Stamford and Justice, 1996). This contrasts with measurements
achieved by brain microdialysis which suffers from relatively large
probe size (minimum ∼200 μm), variable in vivo recovery which is
dependent on flow rate and tissue stabilisation/probe fouling, the
need to collect finite volumes of dialysates depending on the chosen
detection method, and poor time resolution (1–10 min).
To achieve our aim, carbon fibre bundle electrodes were designed
for O2 monitoring, as carbon fibre has very weak paramagnetic
properties compared to metal electrodes which can produce suscep-
tibility artifacts and image degradation; we have previously used
carbon fibre electrodes for electrical stimulation of the brain in fMRI
studies in animals and demonstrated their compatibility with fMRI
data acquisition (Austin et al., 2003, 2005). In order to mimic changes
in O2 utilisation and supply during neuronal activation we have
changed the concentration of O2 in the inspired air. While previous
reports have calibrated the BOLD signal against CBF/CMRO2 coupling
using hypercapnia (Davis et al., 1998; Leontiev, et al., 2007), to our
knowledge, this is the first report to show simultaneous recording and
demonstrate direct correlation of BOLD and real-time tissue O2 signal
changes, thus laying the foundation for simultaneous measurement of
metabolic and fMRI responses to neuronal activation. The long-term
(months) in-vivo signal stability of the LIVE O2 sensor (Bolger and
Lowry, 2005) also means that the relationship of these changes to
defined stimuli and behavioural response can be determined in an
exactly parallel way to the use of fMRI in human neuropsychology.
Materials and methods
LIVE oxygen sensors
A wide variety of sensors have been used for direct monitoring of
O2 with the majority of measurements obtained using constant
potential amperometry (CPA) at noble metal microelectrodes such
gold (Cooper, 1963; El-Deab and Ohsaka, 2003; Holmström et al.,
1998) or platinum (Clark et al., 1958; Hitchman, 1978; Travis and
Clark, 1965; Ward et al., 2002). The use of carbon-based electrodes
has been reported by several groups (Bazzu et al., 2009; Bolger and
Lowry, 2005; Lowry and O'Neill, 1996; Venton et al., 2003) and they
are often the electrode of choice because of their in-vivo stability and
minimal surface poisoning (Bolger and Lowry, 2005). Reduction of O2
at carbon electrodes is a two-electron processes producing H2O2:
O2 þ 2Hþ þ 2e−→H2O2
H2O2 þ 2Hþ þ 2e−→2H2O
Since H2O2 is poorly oxidised at carbon irreversible electrochemical
behaviour is observed (Taylor and Humffray, 1975; Zimmerman and
Wightman, 1991). The rate-limiting step for this reduction is the
initial one-electron step followed by protonation of the superoxide
ion and further reduction (Taylor and Humffray, 1975).
Single thread Nafion®-coated carbon fibre cylinder electrodes (CFEs,
diameter 5 μm), coupled with fast cyclic voltammetry, have previously
beenused for themeasurementof dissolvedO2 inanaesthetisedanimals
(Venton et al., 2003; Zimmerman and Wightman, 1991). However, the
ideal sensor size for such in vivo applications should be at least equal to,
or greater than, the dimension of the blood capillaries (∼100 μm) in
order to prevent direct blood sampling of dissolved O2 (Bazzu et al.,
2009; Bolger and Lowry, 2005; Lowry and O'Neill, 1996). The
unmodified carbon fibre bundle electrodes used in this study were
thus designed with a diameter of ∼100 μm and were prepared by
attaching carbon fibre threads (individual diameter ∼10 μm, Good-
fellow, Cambridge, UK) to Flexivolt® copper wire (Radionics, Northants,
UK) using conductive silver epoxy (Chemtronics, Georgia, USA). Fibres
were encased within a double-layered plastic insulating sheath. The
carbon fibre bundle was exposed ca. 1.5 mm beyond the insulating
sheath for insertion into the cortex. Although carbon fibre is a non-
magnetic material, the conductive wire and silver epoxy can cause
significant image artefacts if positioned close to the animals' head. To
prevent this, the total length of the carbon fibre threads used was
sufficiently long so that the connection point lay outside the RF coil once
the animal was inside the probe.
Animal preparation
Male Sprague–Dawley rats (217±19 g; n=3) were anaesthetised
with 2% isoflurane in 30% O2:70% N2O. The animals were positioned in
a stereotaxic frame and the skull was exposed via a midline incision in
the scalp. Three burr holes were drilled in the skull above the right
hemisphere, and a recording CFE was positioned stereotaxically in the
hindpaw motor cortex (1 mm posterior to Bregma, 3 mm lateral and
at a depth of 1.5 mm). Via the remaining two burr holes, reference and
auxiliary electrodes (CFEs) were positioned at the same depth in the
same hemisphere anterior to the recording electrode (ca. 2.5 and
3.5 mm anterior to Bregma). The electrodes were initially fixed in
position using superglue, and subsequently the exposed surface of the
skull was covered in dental cement to secure the electrodes in
position and seal the surface. The reference potential provided by the
CFE in brain tissue was measured against a saturated calomel
electrode (SCE) and found to be 23±10 mV. Before experiments
commenced, the recording potential (−900 mV) was applied to the
working electrode (CFE sensor) for at least 30 min to allow the
electrode to settle (stable background) in situ.
ECG electrodes were positioned subcutaneously for measurement
of heart rate, and core body temperature was monitored and
regulated at 37±0.5 °C with a rectal probe and circulating warm
water system. Isoflurane concentration was reduced to ca. 1.6% for the
remainder of the experiment. In one animal the left femoral artery
was cannulated for continuous blood pressure monitoring. Following
surgery the animals were positioned in a home-built 50 mm i.d.
quadrature volume resonator with integral stereotaxic frame.
fMRI
MRI measurements were performed on a horizontal bore 7 Tesla
magnet with a Varian Inova spectrometer. For the fMRI experiments, a
multi-echo gradient echo imaging sequencewas usedwith the following
parameters: flip angle=20°; relaxation time (TR)=27.3 ms; echo time
(TE)=7, 14, 21 ms (acquired within one TR); acquisition ma-
trix=192×64 (zero filled to 192×96); 1 slice, voxel size
0.47 mm×0.47 mm×1.5 mm; single average (dc offset corrected off-
line); 1.75 s per acquisition. A multi-echo acquisition improves the
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sensitivity to BOLD contrast changes in areas affected by local
macroscopic T2* artefacts (i.e. due to the carbon electrodes) by
calculating the arithmetic mean of non-optimal shorter echo-times to
increase statistical power (Lowe et al., 2002, 2007; Ireland et al., 2005).
Slice positionwas7 mmposterior to the rhinalfissure (1 mmposterior to
Bregma), corresponding to the centre of the hindpaw motor cortex. For
the O2 removal (100% N2O) experiments each fMRI run consisted of an
initial baseline period of 102 images (ca. 3 min), followed by three blocks
of 189 images during which O2 was removed for the first 17 images (ca.
30 s) and followed by 5 min for baseline recovery. This protocol was
repeated a minimum of twice in each animal. For the increased O2
experiments each fMRI run consisted of an initial baseline period of 172
images (ca. 5 min), followed by three blocks of 206 images duringwhich
O2was increased for thefirst 34 images (ca.1 min) and followedby5 min
for baseline recovery. This protocol was repeated aminimum of twice in
each animal for 100% O2 and once for 70% and 50% O2 (two blocks from
one of the 50% O2 runs were lost due to technical problems).
In one animal, after all of the BOLD fMRI data sets had been
acquired 0.15 ml of ferumoxtran-10 (12 mg Fe/kg; Sinerem®,
Guerbet, France; gift from Guerbet Research) was injected intrave-
nously for CBV fMRI measurements. This USPIO agent exhibits a long
blood half-life (5–6 h in rat (Li and Freeman, 2007)), enabling CBV
measurements to be made over a prolonged period following
intravenous administration. CBV fMRI data sets were acquired using
the same imaging paradigm as for the BOLD acquisition.
Following data acquisition, mean echo images were calculated
from the arithmetic mean of the individual echo images. Subsequent-
ly, the brain was manually masked to remove extra-cranial signal and
images were Gaussian smoothed with a kernel 2 times the in-plane
resolution. Regions of interest (ROIs) were delineated on the images,
either encompassing the hindpaw motor cortex for the O2 removal
experiments or the entire brain for the increased O2 experiments
(where signal changes were very small and assuming consistent
global effects), and time-courses of signal response were obtained for
each ROI from the mean echo data.
Electrochemical experiments in vitro
Experiments in vitro were carried out in a phosphate buffered
saline (PBS) solution, pH 7.4: NaCl (BDH, AnalaR grade, 0.15 mol/L),
NaH2PO4 (BDH, AnalaR grade, 0.04 mol/L), and NaOH (BDH, AnalaR
grade, 0.04 mol/L) prepared using deoxygenated doubly distilled
water. All experiments were performed in a standard three-electrode
glass electrochemical cell containing 15 mL PBS at room temperature.
For cyclic voltammetry experiments, where the applied potential is
scanned at a fixed scan rate between defined potential limits, a
saturated calomel electrode (SCE) was used as the reference
electrode, and a Pt wire served as the auxiliary electrode. To attain
effective deaeration, the PBS solution was vigorously purged with O2-
free N2 (BOC Gases, average O2 content 2 ppm, maximum O2 content
5 ppm) for at least 30 min before recording began and a N2
atmosphere maintained over the cell thereafter. In experiments
involving solution O2, either atmospheric air (from a RENA 101 or 102
air pump) or pure O2 (compressed gas) was bubbled through the PBS
for a similar period and the appropriate gaseous atmosphere
maintained over the quiescent solution during recording of the
currents.
For post in-vivo calibrations involving constant potential ampero-
metry (CPA), where the detecting electrode is held at a constant
potential sufficient to detect the oxidation or reduction of the target
substance, the same three-electrode (sensor, reference and auxiliary)
configuration of CFEs was maintained and the concentrations of
solution O2 taken as 0 μM (N2-saturated), 200 μM (air saturated
(Bourdillon et al., 1982; Zhang and Wilson, 1993)) and 1260 μM (O2-
saturated (Bourdillon et al., 1982)), respectively.
LIVE instrumentation and software
Cyclic voltammetry and CPA were carried out using a low-noise
potentiostat (Biostat II, Electrochemical and Medical systems, New-
bury, UK). Implanted electrodes were connected to the potentiostat
through the Flexivolt® copper wire (Radionics), gold electrical
contacts (Plastics One, Roanoke, VA, USA) and a screened six core
cable (Plastics One). Data acquisition was performed with a notebook
PC, a Powerlab/400 interface system (ADInstruments Ltd., Oxford,
UK) and Chart for Windows (v 4.0.1) software (ADInstruments Ltd.).
A low-pass digital filter (50 Hz cut-off) was used to eliminate mains
AC noise and all data was recorded at 10 Hz.
All analysis was performed using Microsoft Excel and Prism
(GraphPad Software Inc., CA, USA). The significance of differences
observed was estimated using the Student's t-test for paired
observations. Two-tailed levels of significance were used and
pb0.05 was considered to be significant. All data are presented as
mean±S.E.M.
Results
LIVE O2 signal characterisation and validation
In order to determine the position of O2 reduction on the voltage
axis of the carbon fibre cylinder electrodes (CFEs) cyclic voltammetry
was performed. Characterisation voltammograms were recorded at
100 mV/s in N2 (background) and air saturated PBS solutions. The
potential chosen for CPA O2 detection was −900 mV which is in the
mass-transport limited region after the peak potential for O2
reduction (ca. −800 mV).
In order to demonstrate that the LIVE CFE signal was sensitive to
changes in tissue O2 concentration in vivo with the animal inside the
MRI radiofrequency (RF) coil the O2 content of the inspired gases was
either reduced (100% N2O:0% O2) for 30 s or increased (to 100%) for
ca. 1 min to induce brief periods of hypoxia and hyperoxia
respectively (Fig. 1). On decreasing the O2 content the amperometric
signal began to rapidly decrease after ca. 30 s, reaching a plateau and
returning to baseline within 1 min of ceasing the O2 decrease.
Conversely, when the O2 content was increased the current began
to increase after a short delay (ca. 15 s) and continued to increase over
the 1-min interval until the inspired O2 was returned to the normal
70% N2O:30% O2. The O2 levels then remained elevated for ca. 30 s
before returning to baseline levels in a similar time interval to that
observed for 100% N2O.
Simultaneous LIVE O2 and BOLD fMRI monitoring
Having demonstrated that changes in brain tissue O2 could be
monitored in real-time using LIVE with our CFEs and within the RF
coil, experiments were then performed to simultaneously record LIVE
and BOLD data. Following a baseline period of 3 min, the O2 content of
the inspired gases (70% N2O:30% O2) was either reduced (100%
N2O:0% O2) for ca. 30 s or increased (to 50%, 70% or 100%) for ca.
1 min. This sequence was repeated several times (n values) in each
animal for each condition. ECG was maintained between ca. 370 and
390 bpm and no significant effects of the alterations in inspired gases
were detected in any of the animals. Similarly, in the one animal in
which an arterial line was inserted, MABP was maintained at a
constant level (105–115 mm Hg) throughout and no significant
changes were observed on either decreasing or increasing inspired O2
(Table 1). However, following complete O2 removal a transient
reduction in MABP occurred (maximum decrease 5.3±0.3 mm Hg;
n=3), which began approximately 10 s after restoration of 30% O2
and had completely reversed within ca. 100 s.
Tissue O2 and BOLD signals showed a marked negative response
during the brief episodes (30 s, repeated several times (n values) in
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each animal) of complete O2 removal (Fig. 2), whichwill both increase
deoxyhaemoglobin levels and decrease tissue O2. The average O2
current recorded using CPA decreased by 37.4±8.3 nA (n=10,
pb0.0015) below baseline (−490.0±57.8 nA). Because of the high
baseline currents observed in vivo it is not possible to calculate a
percentage change in O2 levels from the in vivo signal (Lowry et al.,
1997). However, post in vivo calibrations of the CFEs indicate that the
sensitivity for O2 is −287.6±78.3 nA/mM (n=3). Therefore, using
these calibrations the decrease in O2 observed corresponds to an
approximate change in concentration of 129.9±28.6 μM, n=10. The
BOLD signal decrease and return to baseline followed the same time
course as that of tissue O2 with a maximum decrease of 6.6±1.5%
(n=10) below baseline. A correlation analysis (Δ BOLD vs. Δ Current)
indicates a significant correlation between the changes observed in
the two signals (r=0.7898, pb0.007).
Conversely, when the inspired O2 was increased positive changes in
both the tissue O2 and BOLD signals were observed (Fig. 3). The average
O2 current increased from a baseline of−323.8±20.7 nA (n=36) to a
maximum of 16.61±3.97 nA (n=9, pb0.004) for 50% O2, 20.72±
3.76 nA (n=9, pb0.0006) for 70% O2, and 32.80±4.65 nA (n=18,
pb0.0001) for 100% O2 (r2=0.974). Using post in vivo calibrations the
increases in O2 observed correspond to approximate changes in
concentration of 57.69±13.77 μM, (50% O2, n=9), 71.95±12.75 μM,
(70% O2, n=9) and 113.90±16.13 μM, (100% O2, n=18) respectively.
The BOLD signal increased and returned to baseline following the same
time course as that of tissue O2with amaximum increase above baseline
of 0.67±0.09% (n=9) for 50% O2, 0.84±0.08% (n=9) for 70% O2, and
1.07±0.09% (n=18) for 100% O2 (r2=0.999).
Simultaneous LIVE O2 and CBV fMRI Monitoring
In order to investigate the role of vasodilatory haemodynamics
simultaneous LIVE and CBV fMRI was performed during the 100% O2
paradigm. The CBV fMRI measurements were obtained using a long
half-life iron oxide contrast agent (ferumoxtran-10; Sinerem®,
Guerbet, France) to label the blood pool (Mandeville et al., 2004). A
moderate increase (ca. 4%) in the CBV fMRI signal, indicating a
reduction in USPIO concentration and hence blood volume in the
brain, was observed during the periods of 100% O2 (Fig. 4; CBV signals
have been inverted to illustrate the reduction in CBV). Positive
changes in the tissue O2 signal were observed as before.
Fig. 1. Typical current-time responses recorded at an implanted carbon fibre electrode
(CFE) for (a) successive 30 s decreases (100% N2O: 0% O2), and (b) 1 min increases (0%
N2O:100% O2), in inspired O2. CFE implanted in the motor cortex of a male Sprague-
Dawley rat anaesthetised with 1.6% isoflurane in 70% N2O:30% O2. Hashed lines indicate
periods of hypoxia and hyperoxia induced by changing the O2 content of the inspired
gases.
Table 1
Effect of O2 challenges on MABP. No significant differences were found between
baseline recordings and those obtained during alteration of inspired O2 concentration:
100% O2 (each period is the average of two separate runs), 70%, 50% and 0% O2 (data
from a single run).
MABP (mm Hg)
100% Oxygen 70% Oxygen 50% Oxygen 0% Oxygen
Mean S.E.M. Mean S.E.M. Mean S.E.M. Mean S.E.M.
Baseline #1 111.2 0.1 106.4 0.0 109.0 0.0 105.3 0.2
Oxygen #1 111.2 0.3 106.6 0.1 108.1 0.1 102.3 0.0
Baseline #2 111.7 0.1 108.3 0.1 107.2 0.0 104.0 0.3
Oxygen #2 111.5 0.2 108.1 0.1 106.9 0.1 103.2 0.0
Baseline #3 111.8 0.1 108.6 0.0 107.4 0.1 102.9 0.2
Oxygen #3 111.9 0.3 107.9 0.1 108.0 0.1 103.6 0.1
Baseline #4 112.3 0.2 110.9 0.3 106.3 0.0 102.8 0.1
Fig. 2. Typical time courses for brain tissue O2 (a) and BOLD fMRI (b) signals recorded
simultaneously in response to successive 30 s periods (hashed lines) of decreased
(100% N2O:0% O2) inspired O2. BOLD data taken from ROI in region of recording CFE
(hindpaw motor cortex). CFE background current subtracted from tissue O2 signals.
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Discussion
In this study we have developed and validated techniques for
simultaneous measurement of fMRI responses and tissue O2 concen-
tration via LIVE. The results presented demonstrate the practical
feasibility of obtaining real-time information about O2 delivery and
utilisation during fMRI acquisition. In the experiments described here,
we have artificially decreased or increased blood and tissue O2
content through variation of inspired gases and shown correlation
between the fMRI and LIVE signals. The BOLD signal is based on a
combination of local changes in deoxyhaemoglobin content, cerebral
blood volume (CBV) and regional cerebral blood flow (CBF). Under
the current experimental conditions the changes observed are likely
to reflect mainly changes in deoxyhaemoglobin levels, although there
may also be associated changes in CBF and CBV. Thus, during complete
O2 removal, deoxyhaemoglobin levels will increase markedly
throughout the circulation and this in itself will give rise to a decrease
in both fMRI and LIVE O2 signals. However, there may also be a
compensatory increase in CBF and/or CBV as part of the autoregula-
tory response. During the period of O2 removal this increase in
cerebral perfusion is expected to have relatively little effect on the
fMRI signals as the blood is likely to be completely deoxygenated
already and increased flow rate will not decrease the signal further. It
is possible that increased cerebral perfusion may potentiate the O2
signal decrease by causing O2 to be removed from the brain tissue
(reversal of normal O2 gradients). However, given the short period of
O2 removal, it is perhaps more likely that increased perfusion
contributes to the very rapid return to baseline values once O2 is
returned to the inspired gases.
It is generally assumed that haemoglobin is fully oxygenated on
leaving the lungs under normal (30% O2) conditions (Hsia, 1998),
however it is possible that under anaesthesia this is not the case
Fig. 3. Averaged time courses (Mean±SEM) for BOLD fMRI (left) and brain tissue O2 (right) signals recorded simultaneously in response to successive ca. 1 min periods (hashed
lines) of increased inspired O2: (a, n=7) 0% N2O:100% O2; (b, n=9) 30% N2O:70% O2; (c, n=18) 50% N2O:50% O2. BOLD data taken from ROI encompassing whole brain (1.5 mm
thick imaging slice) and CFE background current subtracted from tissue O2 signals.
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(Seagard et al., 1985). Thus, when inspired O2 is increased, the
observed effects may arise through a combination of increased
haemoglobin oxygenation (i.e. reduced deoxyhaemoglobin in the
brain) and an increase in the amount of dissolved O2 in the blood. The
latter would be expected to have the effect of increasing tissue O2
concentration (and hence LIVE O2 signal) and also decreasing the rate
of haemoglobin deoxygenation as it passes through the brain (and
hence fMRI BOLD signal). Interestingly, molecular O2 has a weak
paramagnetic effect (Tadamura et al., 1997) which would reduce the
BOLD signal, and thus the observed effects may be a balance of the two
opposing influences. It has been shown previously that a transient
increase in inspired O2 does not cause an increase in CBF (Lowry et al.,
1998), and it is unlikely, therefore, that the observed BOLD changes
can be explained by a vasodilatory haemodynamic effect.
To investigate this, in one animal we also obtained simultaneous
LIVE and CBV fMRI measurements during 100% O2 administration.
Since a reduction in CBV would not be expected to result in an
increased BOLD signal (as measured under the same conditions), the
effect of the observed decrease in CBV must again be smaller than the
effects of increased pO2 in the blood on the oxygenation level of
haemoglobin. The decrease in CBV suggests a vasoconstrictory effect
of hyperoxia, which is in agreement with very recent work from
MacVicar's group, who showed that levels of prostaglandin E2 (PGE2)
are modulated by extracellular levels of lactate and, thus, in turn
tissue pO2 (Gordon et al., 2008). PGE2 produced in astrocytes via the
arachidonic acid pathway has recently gained much support as a key
mediator of vasodilation in the brain (for review see Iadecola and
Nedergaard, 2007). Consequently, Gordon et al. (2008) suggest that
steady-state CBFmay be altered by levels of tissue pO2 (and lactate) as
a result of astrocytic regulation and modulation of PGE2 levels. Thus,
under hyperoxic conditions, tissue O2 is high and lactate will be low,
leading to a reduction in PGE2 release and, consequently, vasocon-
striction. This hypothesis has only been tested in ex vivo preparations
to date, whilst the current data provide preliminary in vivo support
and suggest that our combined LIVE/fMRI approach may provide a
sensitive in vivo means to further investigate this concept.
Whatever the underlying causes are for the global changes in
tissue oxygenation observed, it is clear that in both experimental
conditions the BOLD signal, which reflects the local concentration of
deoxyhaemoglobin, provides a close correlate of the tissue O2
dynamics, or, alternatively, that tissue O2 concentration can serve as
an index of changes in the magnitude of the BOLD response. We have
previously shown that LIVE measurements of tissue O2 are closely
related to CBF (Lowry et al., 1997), and it has been assumed, but not
proven, that BOLD fMRI signals induced during neuronal activity
reflect tissue O2 levels (Dousset et al., 1999; Thompson et al., 2003,
2004, 2005; Raichle, 1998). The findings of this study now provide
strong evidence to support this assumption and demonstrate that this
novel combined technology provides a means of interrogating the
relationships between metabolism, haemodynamics and neuronal
activity. Moreover, our findings provide support for the use of LIVE to
predict the BOLD response under conditions that are not amenable to
the magnet environment, such as in awake rats performing specific
behavioural tasks. Preliminary data indicate that LIVE measurements
of tissue O2 in the amygdala during extinction of fear conditioning (Li
et al., 2009), in the nucleus accumbens during anticipated reward
(Gilmour et al., 2009), and in the medial prefrontal cortex and nucleus
accumbens following administration of glutamatergic psychostimu-
lants (Ishiwari et al., 2009), are consistent with changes in the BOLD
response seen in equivalent brain regions of human volunteers
undergoing similar manipulations. Given that fMRI enables one to
define the entire brain 3-dimensional pattern of neuronal activity, and
BOLD fMRI specifically permits high resolution capture of O2 levels
throughout the brain, LIVE cannot substitute for either of these
methodologies in terms of providing whole brain information.
However, with the possibility of implanting several electrodes at
any one time the measurement of the synchrony of activity with high
temporal resolution between brain regions is a realistic possibility. In
addition, LIVE technology can be applied to the measurement of many
different neurochemicals, both metabolic and neuronal. Thus this
combinedmethodology opens up numerous avenues for investigating
the direct relationship between fMRI signal changes and the
underlying neurochemistry across a range of different stimulation
paradigms. Future work will concentrate on investigating the
relationship between BOLD and tissue O2 when variations in
metabolic demand are induced by local stimulation.
Conclusion
The presented results indicate that the BOLD signal, which reflects
the local concentration of deoxyhaemoglobin, provides a close
correlate of tissue O2 dynamics. These findings support the use of
LIVE monitoring of tissue O2 concentration as an index of changes in
the BOLD response under conditions that are not amenable to the
magnet environment, such as in conscious rodents performing
specific behavioural tasks. Whilst local field potentials and/or single
unit activity can be monitored in behaving animals, measurement of
the biochemical parameters underlying fMRI offers a directly
translational approach to the study of brain activity underlying
function. The simultaneous acquisition of tissue O2 concentration and
fMRI data represents a significant step forward in modern neurosci-
ence as it provides a viable awake animal surrogate of human fMRI
experimentation, and thus is an effective translational tool which can
better enable the comparison of human and animal research.
Fig. 4. Averaged time courses (Mean±SEM) for brain tissue O2 (a) and CBV fMRI
(b) signals recorded simultaneously in response to ca. 1 min period (hashed lines) of
100% inspired O2 (n=4). CBV data taken from ROI encompassing whole brain (1.5 mm
thick imaging slice) and have been inverted for ease of interpretation, since a positive
change in the CBV signal (as measured) reflects a decrease in CBV. CFE background
current subtracted from tissue O2 signals.
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